TCL Archive Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion May 31, 2002
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012